Tartia is right. It won't move much without good news from medium or big market drugs.
I expect $6, 7, 8 until then.
Sorry, I don't trust spi2012. It could be a little better than Neulasta or biosimilars. That doesn't mean sppi can fight against giant companies like Amgen or other big biosimilar companies. Raj should find rare disease drugs or new technologies for cure. Raj should more focus on Chinese or Indian markets for existing drugs. I know he is doing that. But put more enery there.
Fingers crossed for this one.
But as you said it is not going to be easy to get fda approved.
Raj is so quiet so far. It sounds he doesn't have confidence for his company.
He is stuck now!!! He is old. He may wrap up sppi and sell it around $7.
That's what I am talking about.
The sales are very challenge.
Stupid Raj, please addmit spi2012 is your another trap.
I wouldn't spend a lot of money for phase3.
Go, find another good candidate!!!
I thought you know Raj. Now you know why Raj kept talking about spi-2012 only. There are nothing going on other than spi-2012. I don't even trust spi-2012. SPPI may go down to a buck.
I really worried about sppi business strategy.
SPI-2012 will not be blockbuster even if it gets approved.
It should be a lot more superior than Naulasta. Otherwise, biosimilar of Naulasta will kill spi-2012.
I like Apaziquine but Raj keeps talking about spi-2012.Most of sppi's drugs are so crowded in the market.
Lots of legal issues comes out in crowed market.
I am back now. I only had a time on Saturday morning when I was driving from Orange County to San Diego. It was small building. Hope one in Las Vegas is a lot bigger.